Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in May:

• The SunTrust Robinson Humphrey 5th Annual Life Sciences Summit on Tuesday, May 7th in New York City. Management will participate in investor meetings.  
• The RBC Capital Markets Global Healthcare Conference on Wednesday, May 22nd in New York City. Management will present at 2:05 p.m. ET and will also participate in investor meetings.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact: Alex Dasalla [email protected]

Source: Collegium Pharmaceutical, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Collegium Pharmaceutical (COLL) PT Lowered to $48 at Barclays
• Interim Report - RIAS A/S
• Instagram and TikTok Changed Nail Expectations: Why Not Nails Academy Explains Why Education Matters More Than Ever